Total Payments
$121,198
2024 Payments
$21,363
Companies
2
Transactions
91
Medicare Patients
592
Medicare Billing
$77,368
Payment Breakdown by Category
Research$119,917 (98.9%)
Travel$1,086 (0.9%)
Food & Beverage$195.47 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $119,917 | 88 | 98.9% |
| Travel and Lodging | $1,086 | 1 | 0.9% |
| Food and Beverage | $195.47 | 2 | 0.2% |
Payments by Type
Research
$119,917
88 transactions
General
$1,281
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $121,102 | 90 | $0 (2024) |
| Medtronic USA, Inc. | $95.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,363 | 43 | NEUROPACE, INC. ($21,363) |
| 2023 | $23,888 | 26 | NEUROPACE, INC. ($23,888) |
| 2018 | $59,702 | 9 | NEUROPACE, INC. ($59,702) |
| 2017 | $16,245 | 13 | NEUROPACE, INC. ($16,150) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $2,000.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $802.50 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $300.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 09/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $75.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 08/29/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 08/29/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 08/29/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,000.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 06/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 06/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 06/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $150.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 06/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $90.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 06/30/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $45.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $1,102.50 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $850.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $832.50 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $800.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $700.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $700.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $600.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $550.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
| 03/31/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | — | Cash or cash equivalent | $475.00 | Research |
| Study: Nautilus Study • Category: Epilepsy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Post Approval Study | NEUROPACE, INC. | $57,871 | 7 |
| Nautilus Study | NEUROPACE, INC. | $45,250 | 69 |
| RNS System Long-term Treatment Clinical Investigation | NEUROPACE, INC. | $14,964 | 10 |
| RNS Long Term Trmt Clin Trial | NEUROPACE, INC. | $1,831 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 131 | 169 | $187,205 | $16,468 |
| 2022 | 6 | 121 | 171 | $181,554 | $17,560 |
| 2021 | 7 | 159 | 241 | $192,541 | $20,091 |
| 2020 | 9 | 181 | 285 | $223,853 | $23,250 |
Total Patients
592
Total Services
866
Medicare Billing
$77,368
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 26 | 45 | $129,776 | $7,247 | 5.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 32 | $5,070 | $2,433 | 48.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 15 | 17 | $25,035 | $1,811 | 7.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 17 | $4,335 | $1,673 | 38.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $12,756 | $1,574 | 12.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 30 | $8,958 | $1,200 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 13 | $1,275 | $530.30 | 41.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 29 | 56 | $139,255 | $9,258 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 40 | $6,364 | $2,792 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 24 | 26 | $5,869 | $2,400 | 40.9% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 16 | 18 | $21,530 | $1,973 | 9.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 17 | $7,197 | $969.72 | 13.5% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Facility | 2022 | 11 | 14 | $1,339 | $166.96 | 12.5% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 30 | 61 | $143,275 | $10,068 | 7.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 53 | $8,485 | $3,636 | 42.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 46 | $17,314 | $2,629 | 15.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $12,190 | $1,905 | 15.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 19 | 33 | $7,973 | $1,029 | 12.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 17 | $1,811 | $667.05 | 36.8% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Facility | 2021 | 12 | 13 | $1,493 | $155.35 | 10.4% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 30 | 67 | $152,988 | $11,378 | 7.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 48 | 59 | $9,187 | $3,335 | 36.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 18 | 56 | $13,006 | $1,714 | 13.2% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 15 | 16 | $17,988 | $1,665 | 9.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 14 | $9,166 | $1,589 | 17.3% |
About Dr. Barbara Jobst, M.D
Dr. Barbara Jobst, M.D is a Neurocritical Care healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790876696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Jobst, M.D has received a total of $121,198 in payments from pharmaceutical and medical device companies, with $21,363 received in 2024. These payments were reported across 91 transactions from 2 companies. The most common payment nature is "" ($119,917).
As a Medicare-enrolled provider, Jobst has provided services to 592 Medicare beneficiaries, totaling 866 services with total Medicare billing of $77,368. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurocritical Care
- Other Specialties Neurology
- Location Lebanon, NH
- Active Since 09/27/2006
- Last Updated 12/12/2025
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1790876696
Products in Payments
- RNS System (Device) $75,852
- RNS Neurostimulator Kit (Device) $45,250
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurocritical Care Doctors in Lebanon
Victoria Lawson, Md, MD
Neurocritical Care — Payments: $62,468
Neurocritical Care $62,468
Andrew Pachner, M.d, M.D
Neurocritical Care — Payments: $46,981
Neurocritical Care $46,981
Jeffrey Cohen, M.d, M.D
Neurocritical Care — Payments: $17,612
Neurocritical Care $17,612
Dr. Erik Kobylarz, Md, Phd, MD, PHD
Neurocritical Care — Payments: $2,576
Neurocritical Care $2,576
Vijay Thadani, M.d, M.D
Neurocritical Care — Payments: $114.99
Neurocritical Care $114.99
Lara Ronan, Md, MD
Neurocritical Care
Neurocritical Care